Clearstead Advisors’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-590
| Closed | -$4.61K | – | 2808 |
|
|
2025
Q1 | $4.61K | Buy |
590
+100
| +20% | +$781 | ﹤0.01% | 1764 |
|
|
2024
Q4 | $2.29K | Hold |
490
| – | – | ﹤0.01% | 1827 |
|
|
2024
Q3 | $2.64K | Hold |
490
| – | – | ﹤0.01% | 1809 |
|
|
2024
Q2 | $4.32K | Hold |
490
| – | – | ﹤0.01% | 1705 |
|
|
2024
Q1 | $4.86K | Buy |
490
+70
| +17% | +$694 | ﹤0.01% | 1178 |
|
|
2023
Q4 | $4.73K | Sell |
420
-420
| -50% | -$4.73K | ﹤0.01% | 1167 |
|
|
2023
Q3 | $5.69K | Buy |
840
+420
| +100% | +$2.84K | ﹤0.01% | 1214 |
|
|
2023
Q2 | $3.81K | Hold |
420
| – | – | ﹤0.01% | 1076 |
|
|
2023
Q1 | $2.71K | Buy |
+420
| New | +$2.71K | ﹤0.01% | 1091 |
|